Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Oct 26 - Oct 31
Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used clinically to treat type 2 diabetes mellitus
13-25)19(27)28-3
and rhesus macaques with t1/2 of >8
DHODH-IN-16 is a potent dihydroorotate dehydrogenase (DHODH) inhibitor with an IC50 of 0
but only when relatively high drug concentrations (1 mM) are used
Tivozanib (hydrate) Size:Contact [email protected] for quotation Liraglutide is a glucagon-like peptide-1Tivozanib, also known as AV 951 and KRN 951, is an orally active, ATP competitive, small molecule, quinoline urea derivative. Tivozanib is a pan VEGFR tyrosine kinase inhibitor. In vitro: Tivozanib markedly inhibited the ligand induced phosphorylation of VEGFR1\2 and 3 with the IC50 value of 30 nM\6. 5 nM and 15 nM, respectively. Tivozanib also exihibited inhibitory effects on PDGFR and c Ki with the IC50 value of 1. 72 and 1. 63 nmol L, respectively.
US$ 169.29
US$ 1497.50
US$ 222.50
US$ 222.50
US$ 147.50
US$ 147.50
US$ 50.00
US$ 14.99